High-Vitamin Butter Oil for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

High-Vitamin Butter Oil for Health & Longevity

Created on 09/10/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A concentrated milk fat sold for vitamin A and the animal form of vitamin K2. No trial has given the oil to people and measured an outcome; the case rests on uncontrolled 1930s observations and isolated-vitamin work at far higher doses. The label declares no vitamin content, and concentrated vitamin A tracks with weaker bones and more hip fractures. (Full Review)

Protocol

Standard manufacturer protocol
Half a teaspoon (2.5 mL) daily
Liquid, or two capsules; 25 calories and 2.5 g of fat per serving
Best time of day
With the largest fat-containing meal
Absorption depends on dietary fat and bile flow; no circadian advantage demonstrated
Half-life and dose splitting
Splitting across two fat-containing meals
MK-4 circulates with a one-to-two-hour half-life; retinyl esters need no splitting
Time to effect
Vitamin K activity markers
2–4 weeks
Undercarboxylated osteocalcin and dp-ucMGP
Bone density change
6–24 months
Where measurable at all, in the MK-4 trials
The oil itself
No timescale established
No trial has given the oil itself to people

Benefits

Contraindications
  • Pregnancy or planned pregnancy, where total preformed vitamin A would exceed 3,000 µg RAE daily
  • Documented cow's milk protein allergy
  • Chronic liver disease of Child-Pugh Class B or C, or any cirrhosis
  • Systemic retinoids (isotretinoin, acitretin, bexarotene)
  • Established osteoporosis (T-score −2.5 or below) with habitual preformed retinol intake above 1.5 mg daily
    •
Key Interactions
  • Vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon)
  • Tetracycline antibiotics (doxycycline, minocycline)
  • Lipase inhibitors (orlistat)
  • Bile acid sequestrants (cholestyramine, colesevelam, colestipol)
  • Over-the-counter vitamin A sources (cod liver oil, retinyl palmitate multivitamins, mineral oil laxatives)
  • Additive supplement interactions (MK-7, vitamin D3, calcium)
  • High-dose vitamin E (above 800 IU daily)
  • Other intervention interactions (bariatric surgery, pancreatic enzyme insufficiency, very-low-fat diets, high-dose niacin)
    •

Risk & Side Effects

  • Medium: Increased hip fracture risk, and congenital malformations in pregnancy, from preformed vitamin A
  • Low: Chronic hypervitaminosis A; elevated low-density lipoprotein cholesterol; reduced stability of vitamin K antagonist anticoagulation
  • Speculative: Cholesterol oxidation products from heat-processed butterfat; milk protein allergen reactions

Monitoring

Marker Target Why
Serum retinol 1.05–2.09 µmol/L Vitamin A status; the ceiling this product runs into
Fasting retinyl esters Below 10% of total vitamin A Earliest signal of liver vitamin A overflow
Alanine aminotransferase (ALT) 10–26 U/L (men), 8–22 U/L (women) Liver injury from chronic vitamin A excess
Dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP) Below 400 pmol/L Vitamin K sufficiency for artery protection
Undercarboxylated osteocalcin Below 20% of total osteocalcin Vitamin K sufficiency for bone protein activation
25-hydroxyvitamin D 40–60 ng/mL Vitamin D status, which vitamin A competes with
Apolipoprotein B (ApoB) Below 80 mg/dL Cholesterol particle count from added dairy fat
International normalised ratio (INR) Prescribed target, commonly 2.0–3.0 Anticoagulation stability under vitamin K load

Cadence: Baseline draw; liver panel and serum retinol at three months, then every six to twelve months; lipids and 25-hydroxyvitamin D on the same rhythm; INR weekly for the first month in anticoagulated users.

Qualitative Assessment

  • Dental sensitivity, and the dentist's record of new or arrested lesions at six-monthly checks
  • Gum bleeding on brushing, which reflects both vitamin K status and gum health
  • Skin dryness, cracked lips and hair shedding — the earliest outward signs of vitamin A excess
  • Headache on waking or transient visual blurring, which signal raised pressure inside the skull
  • Energy and appetite, since early vitamin A overload presents as fatigue and appetite loss before laboratory changes
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.